United Therapeutics Soars 13% as Court Rules Yutrepia Infringes Its Patent

Liquidia Stock Crashed 57% in a Day After a Delaware Court Ruling. An Appeal Could Decide Whether Shares Rebound.

Liquidia Sinks Another 17% as BofA Cuts Target to $40 From $92 After Court Loss

United Therapeutics Won Its Patent War and Liquidia Collapsed

Liquidia Stock Plunges 57% on UTHR Patent Litigation Setback

LQDA Stock On Track For Worst Week Ever As Analysts Say The Yutrepia Patent Loss Clouds Its Path

Stocks making big moves yesterday: United Therapeutics, Moderna, Jabil, Concentrix, and FactSet

United Therapeutics Just Sent Liquidia Stock Lower After Patent Battle

Stocktwits Wall Street Wrap: Analysts Turn Bullish On Sweetgreen, Target And Airbnb – Liquidia And FICO Face Downgrades

Liquidia (LQDA) Could Be 74% Undervalued As Court Ruling Clouds YUTREPIA Access